Intracellular Self-Assembly of Peptides to Induce Apoptosis against Drug-Resistant Melanoma
- 31 March 2022
- journal article
- research article
- Published by American Chemical Society (ACS) in Journal of the American Chemical Society
- Vol. 144 (16) , 7337-7345
Abstract
Biosynthesis has been a diverse toolbox to develop bioactive molecules and materials, especially for fabricating modified peptides and their assemblies induced by enzymes. Although desired chemical structures and nanoarchitectures have been achieved, the subsequent interferences of peptide assemblies with organelles and the cellular pathways still remain unsolved important challenges. Herein, we developed a new tripeptide, phenylalanine–phenylalanine–tyrosine (Phe–Phe–Tyr, or FFY), which can be intracellularly oxidized and in situ self-assemble into nanoparticles with excellent interference capability with microtubules and ultimately reverse the drug resistance of melanoma. With the catalysis of tyrosinase, FFY was first oxidized to a melanin-like FFY dimer (mFFY) with a diquinone structure for further self-assembling into mFFY assemblies, which could inhibit the self-polymerization of tubulin to induce severe G2/M arrest (13.9% higher than control). Afterward, mitochondrial dysfunction was also induced for overproduction of cleaved caspase 3 (3.1 times higher than control) and cleaved PARP (6.3 times higher), achieving a high level of resistant reversing without chemotherapeutic drugs. In vivo studies showed that the resistant melanoma tumor volumes were reduced by 87.4% compared to control groups after FFY treatment by peritumoral injections. Overall, this tyrosinase-induced tripeptide assembly has been demonstrated with effective intrinsic apoptosis against drug-resistant melanoma, providing a new insight into utilizing biomolecules to interfere with organelles to activate certain apoptosis pathways for treatment of drug-resistant cancer.Keywords
Funding Information
- Natural Science Foundation of Shanghai Municipality (19ZR1478800)
- National Natural Science Foundation of China (21925505, 22075212)
- Shanghai International Scientific Collaboration Fund (21520710100)
- the Program for Professor of Special Appointment (Eastern Scholar) at Shanghai Institutions of Higher Learning
This publication has 52 references indexed in Scilit:
- Inhibition of cisplatin-resistance by RNA interference targeting metallothionein using reducible oligo-peptoplexJournal of Controlled Release, 2015
- Drug-free macromolecular therapeutics – a new paradigm in polymeric nanomedicinesBiomaterials Science, 2015
- BNIP3 supports melanoma cell migration and vasculogenic mimicry by orchestrating the actin cytoskeletonCell Death & Disease, 2014
- Perspectives on poly(dopamine)Chemical Science, 2013
- In vivo modification of tyrosine residues in recombinant mussel adhesive protein by tyrosinase co-expression in Escherichia coliMicrobial Cell Factories, 2012
- New Challenges in Endpoints for Drug Development in Advanced MelanomaClinical Cancer Research, 2012
- Drug Resistance in Melanoma: Mechanisms, Apoptosis, and New Potential Therapeutic TargetsCancer and Metastasis Reviews, 2001
- Interactions of the Sponge-Derived Antimitotic Tripeptide Hemiasterlin with Tubulin: Comparison with Dolastatin 10 and Cryptophycin 1Biochemistry, 1999
- Microtubule-motor activity of a yeast centromere-binding protein complexNature, 1992
- 4',6-Diamidino-2-phenylindole, a fluorescent probe for tubulin and microtubules.Journal of Biological Chemistry, 1985